Acute Effects of Continuous Verses Interval Aerobic Training in Spinal Cord Injury Patient
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05061160 |
Recruitment Status :
Completed
First Posted : September 29, 2021
Last Update Posted : October 24, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Spinal Cord Injuries | Other: Interval Aerobic Exercise training Group Other: Continuous Aerobic Exercise training Group | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 26 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Acute Effects of Continuous Verses Interval Aerobic Training on Autonomic Dysreflexia in Spinal Cord Injury Patient |
Actual Study Start Date : | October 15, 2021 |
Actual Primary Completion Date : | August 30, 2022 |
Actual Study Completion Date : | August 30, 2022 |

Arm | Intervention/treatment |
---|---|
Experimental: Interval Aerobic Exercise training Group
Interval Aerobic Exercise for 4 weeks
|
Other: Interval Aerobic Exercise training Group
Interval Aerobic exercise will be on upper limb Bicycle with a pause of 3 mins interval Interval Aerobic Exercises: Frequency= 3 times per week Intensity= 50% of heart rate reserve for 2 mins 80% of heart rate reserve for 1 min Type= interval aerobic exercise Time= 40 minutes There will be 5 minutes for warm up and 5 minutes for cool down. |
Active Comparator: Continuous Aerobic Exercise training Group
Continuous aerobic exercise for 4 weeks
|
Other: Continuous Aerobic Exercise training Group
Continuous Aerobic exercise will be on upper limb Bicycle Continuous Aerobic Exercise: Frequency= 3 times per week Intensity= 50% of heart rate reserve Type= continuous aerobic exercise Time= 40 minutes There will be 5 minutes for warm up and 5 minutes for cool down. |
- Baroreflex sensitivity (BRS) [ Time Frame: 4th Week ]BRS is the index which is used to quantify the control of baroreflex on the heart rate. Patient's beat to beat arterial pressure and heart rate are measured simultaneously with the Maximal expiratory pressure (MEP) manoeuvre or valsalva manoeuvre. Changes from the baseline to 4 week will be analyzed
- Heart rate reserve (HRR) [ Time Frame: 4th Week ]It is the difference between resting heart rate and maximum heart rate. HRR is primarily use to determine heart rate zone for exercise. HRR can be calculated by subtracting resting heart rate from maximum heart rate. Changes from the baseline to 4 week will be analyzed
- Systolic and diastolic blood pressure [ Time Frame: 4th week ]Changes from the Baseline, Blood pressure is measured through sphygmomanometer
- Oxygen saturation [ Time Frame: 4th Week ]Amount of oxygen in the blood is known as oxygen saturation. normal range is 94-99 percent. Pulse oximeter is used to measure oxygen saturation. Changes from the baseline to 4 weeks
- Pain perception [ Time Frame: 4th week ]Pain is defined as unpleasant sensation which is generated by body as a protective response to prevent further tissue damage. It will be measured with the help of Numeric pain rating scale ranging 0 to 10. where 0 is no pain and 10 is the worst pain imaginable. Changes from the baseline to 4 week will be analyzed
- Exercise self-efficacy [ Time Frame: 4th week ]It is defined as how much an individual consider he eligible to perform the given exercise. Spinal Cord Injury (SCI) Exercise Self Efficacy scale will be provided to the individuals at the baseline and then after 72 hours i.e 3 days of training/week. It has total of 10 questions which allow the participants to indicate on four point scale how much confident they are about the exercise.
- QOL Index-Spinal cord injury version questionnaire [ Time Frame: 4th Week ]QOL index spinal cord injury version is used to assess the quality of life of spinal cord injury patients. It has 32 to 37 items. Each item is rated on scale of 1 to 6.5 scores of 0-30 are calculated.1) quality of life, 2) health and functioning, 3) social and economic life, 4) physiological life, and 5) family life. Changes from the baseline to 4th week will be analyzed

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 50 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Spinal cord injury Patients with level of injury below T 10
- Acute Spinal Cord Injury (Usually Acute phase lasts 8-12 weeks)
- Patients Had experience of Syncope or Postural Hypotension
Exclusion Criteria:
- Neurological disease,
- Cognitive impairment (Mini-Mental State Examination < 22) ,
- Acute and chronic infections

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05061160
Pakistan | |
Armed Forces Institute of Rehabilitation Sciences | |
Rawalpindi, Punjab, Pakistan, 44000 |
Principal Investigator: | Muhammad Iqbal Tariq, MSCPPT | Riphah International University |
Responsible Party: | Riphah International University |
ClinicalTrials.gov Identifier: | NCT05061160 |
Other Study ID Numbers: |
REC/01080 Maryam Tahir |
First Posted: | September 29, 2021 Key Record Dates |
Last Update Posted: | October 24, 2022 |
Last Verified: | October 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Continuous Aerobic Exercise Interval Aerobic Exercise |
Spinal Cord Injuries Wounds and Injuries Spinal Cord Diseases |
Central Nervous System Diseases Nervous System Diseases Trauma, Nervous System |